article thumbnail

A gene test could guide decisions around chemotherapy for bowel cancer

Pharmafile

Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene test which can select which advanced bowel cancer patients will respond the best to chemotherapy. read more

article thumbnail

EMA validates marketing authorisation application for Jemperli with chemotherapy

Pharmafile

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication for Jemperli (dostarlimab) alongside chemotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial

Pharmafile

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of Lynparza (olaparib) and Imfinzi (durvalumab) alongside chemotherapy and bevacizumab. read more

article thumbnail

5 Ways to Better Counsel Patients with Cancer at Your Pharmacy

Digital Pharmacist

Pharmacists can help in improving patients’ pain management understanding by assisting in mitigating the adverse effects of pain medications and by communicating efficiently with providers. Vaccinations can be given before, during, and after chemotherapy. Before chemotherapy, all indicated vaccines should be given to the patient.

article thumbnail

Roche extends Kaiku digital monitoring partnership again

pharmaphorum

Results of the pilot in 45 patients with non-small cell lung cancer (NSCLC) treated with Tecentriq with and without chemotherapy were published in 2020. The data showed that patients as well as physicians and nursing staff found the digital tool allowed “more efficient and focused communication” as well as time savings.

article thumbnail

NICE recommends new life-extending treatment for rare form of gastroesophageal cancer

Pharmafile

Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced or metastatic gastric, gastroesophageal junction, or oesophageal adenocarcinoma, if the tumours express PD-L1. read more.

article thumbnail

AstraZeneca and MSD announce MHRA marketing authorisation of Lynparza combination therapy

Pharmafile

AstraZeneca and MSD have announced that the MHRA has granted marketing authorisation for Lynparza (olaparib) in the UK, when used in combination with abiraterone and prednisone or prednisolone, to treat metastatic castration-resistant prostate cancer (mCRPC) in patients for whom chemotherapy is not recommended. read more